...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis, characterization, antitumor activity and safety testing of novel polyphosphoesters bearing anthracene-derived aminophosphonate units
【24h】

Synthesis, characterization, antitumor activity and safety testing of novel polyphosphoesters bearing anthracene-derived aminophosphonate units

机译:带有蒽衍生的氨基膦酸酯单元的新型聚磷酸酯的合成,表征,抗肿瘤活性和安全性测试

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Novel polyphosphoesters containing anthracene-derived aminophosphonate units, poly(oxyethylene aminophosphonate)s (4 and 5) and poly[oxyethylene(aminophosphonate-co-H-phosphonate)]s (6 and 7), were synthesized via an addition of poly(oxyethylene H-phosphonate)s to 9-anthrylidene-p-toluidine. The IR, NMR (1H, 13C and 31P) and fluorescence emission spectral data of the polymers are presented. The copolymers 6 and 7 were tested for in vitro antitumor activity on a panel of seven human epithelial cancer cell lines. Safety testing was performed both in vitro (3T3 NRU test) and in vivo on ICR mice for genotoxicity and antiproliferative activity. The copolymer 7 showed excellent antiproliferative activity to HBL-100, MDA-MB-231, MCF-7 and HepG2 cell lines. However, the in vitro safety testing revealed significant toxicity to Balb/c 3T3 mouse embryo cells. In contrast, the copolymer 6 showed complete absence of cytotoxicity to Balb/c 3T3 cells, but inhibited the growth of breast cancer cells, cervical carcinoma cells (HeLa) and hepatocellular carcinoma cell cultures after prolonged (72 h) exposure. The polymers (4-6) exhibited low (4 and 6) to moderate (5) clastogenicity in vivo and slightly inhibited bone marrow cell division, compared to Mitomycin C. The subcellular distribution of the copolymers 6 and 7 were studied in model cell culture systems. The tested polyphosphoesters are expected to act in vivo as prodrugs of aminophosphonates and could be valuable as a new class of biodegradable polymer drug carriers.
机译:通过添加聚(氧乙烯),合成了含有蒽衍生的氨基膦酸酯单元,聚(氧乙烯氨基膦酸酯)(4和5)和聚[氧乙烯(氨基膦酸酯-co-H-膦酸酯)] s(6和7)的新型聚磷酸酯。 H-膦酸酯)为9-蒽-对甲苯胺。给出了聚合物的IR,NMR(1H,13C和31P)和荧光发射光谱数据。测试了共聚物6和7在一组七个人上皮癌细胞系上的体外抗肿瘤活性。在ICR小鼠的体外(3T3 NRU试验)和体内均进行了基因毒性和抗增殖活性的安全性测试。共聚物7对HBL-100,MDA-MB-231,MCF-7和HepG2细胞系显示出优异的抗增殖活性。但是,体外安全性测试显示对Balb / c 3T3小鼠胚胎细胞具有明显的毒性。相比之下,共聚物6对Balb / c 3T3细胞完全没有细胞毒性,但在长时间(72小时)暴露后却抑制了乳腺癌细胞,宫颈癌细胞(HeLa)和肝细胞癌细胞的生长。与丝裂霉素C相比,聚合物(4-6)在体内表现出低的(4和6)至中度(5)致胶原性,并略微抑制了骨髓细胞分裂。在模型细胞培养中研究了共聚物6和7的亚细胞分布系统。被测试的聚磷酸酯有望在体内充当氨基膦酸酯的前药,并可能作为一类新的可生物降解的聚合物药物载体而有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号